Ipilimumab/nivolumab/pembrolizumabLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2030卷 / 1期

关键词：

D O I：

10.1007/s40278-024-69043-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：242 / 242

相关论文

共 50 条

[41] Cisplatin/nivolumab/pembrolizumabLack of efficacy: 4 case reports
Reactions Weekly, 2023, 1938 (1) : 407 - 407
[42] Atezolizumab/Nivolumab/PembrolizumabLack of efficacy : 36 case reports
Reactions Weekly, 2024, 2017 (1) : 83 - 83
[43] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1909 (1) : 456 - 456
[44] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 420 - 420
[45] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 365 - 365
[46] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2023, 1939 (1) : 378 - 378
[47] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2024, 2034 (1) : 319 - 319
[48] PembrolizumabLack of efficacy : case report
Reactions Weekly, 2023, 1951 (1) : 276 - 276
[49] Ipilimumab/nivolumab/prednisoneHaemophagocytic lymphohistiocytosis and lack of efficacy: case report
Reactions Weekly, 2022, 1913 (1) : 266 - 266
[50] PembrolizumabLack of efficacy: case report
Reactions Weekly, 2021, 1844 (1) : 367 - 367

← 1 2 3 4 5 →